REMox TB Trial Paves the Way for 21st Century TB Drug Trials
In 2008, TB Alliance launched the first Phase 3 clinical trial of a new TB drug in four decades. The […]
Story
Building Global Capacity for Modern TB Treatment Research
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
Stepping up to Introduce Child-Friendly TB Medicines
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
The Disease Fights Back: The Emergence of Extensively Drug-Resistant Tuberculosis
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
Revealing the Scope of TB Treatment in the Private Sector
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
Unlocking the Combination: Generating Evidence for TB Drug Regimens
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
Progress Through Partnership: Stakeholders in New Treatments
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
From Drugs to Regimens: Transforming TB Drug Development
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those